The Scientific Steering Committee for the innovation grant is comprised of Beverly MK Biller, John Kopchick, Xiaoping Luo, Veronica Mericq, Martin Savage and Christian Strasburger. The Committee oversees a rigorous process of peer review and assessment of eligible projects, before validating its selection of grant awardees.
The names of the applicants and their institutions are completely blinded to the members of the committee to keep the scientific merit of the proposals as the key criteria for selection. All proposals are rated from 1 to 5 (with 5 being the highest) against each of the following criteria:
A final score is then calculated and the projects ranked accordingly. After each round of selection, the GGI secretariat, on behalf of EMD Serono* will contact successful applicants individually to inform them of the status of their application, and if necessary, request additional information.
All projects that pass to the second round of review will have to submit the formal protocol, the budget and a signed document that confirms their acceptance of the grant rules and regulations for advanced applications. Based on this information, the Scientific Steering Committee will make their final acceptance decisions.
The grant recipient will enter into a written agreement with EMD Serono*, which documents the conditions of the grant and the further collaboration between EMD Serono* and the awardee(s).
EMD Serono* retains the exclusive right to issue any press release or any kind of public communication about the Grant for Growth Innovation, the grant(s) and the awardee(s).
EMD Serono* treats all submissions confidentially and information relating to submissions that are not selected for a grant is kept confidential.
By submitting the information requested in the letter of intent you understand and agree that EMD Serono* may share personally identifiable data about you with outside companies or agents working on our behalf, as well as company's subsidiaries and affiliates, to help process the submissions. The importance of security for all personally-identifiable information associated with visitors to the web site is of utmost concern to us. Unfortunately, no data transmission over the internet can be guaranteed to be secure. As a result, EMD Serono* cannot ensure or warrant the security of any information you transmit to us, and you do so at your own risk. Once we receive your personally-identifiable information, we will take reasonable efforts to ensure its security on our systems.
*The biopharma business of Merck KGaA, Darmstadt, Germany